{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:10:03Z","timestamp":1777039803052,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02467-w","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T06:28:26Z","timestamp":1743834506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dihydroartemisinin inhibits lung cancer bone metastasis by modulating macrophage polarization"],"prefix":"10.1186","volume":"30","author":[{"given":"Guihua","family":"Hang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunwang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"2467_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030554","author":"M Cetinkaya","year":"2023","unstructured":"Cetinkaya M, Baran Y. Therapeutic potential of luteolin on cancer. Vaccines (Basel). 2023. https:\/\/doi.org\/10.3390\/vaccines11030554.","journal-title":"Vaccines (Basel)"},{"key":"2467_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188762","volume":"1877","author":"H Que","year":"2022","unstructured":"Que H, Fu Q, Lan T, Tian X, Wei X. Tumor-associated neutrophils and neutrophil-targeted cancer therapies. Biochim Biophys Acta Rev Cancer. 2022;1877: 188762. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188762.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2467_CR3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00262-023-03393-8","volume":"72","author":"Y Tanaka","year":"2023","unstructured":"Tanaka Y, Nakai T, Suzuki A, Kagawa Y, Noritake O, Taki T, Hashimoto H, Sakai T, Shibata Y, Izumi H, Nosaki K, Udagawa H, Zenke Y, Matsumoto S, Yoh K, Miyazaki S, Sakamoto N, Sakashita S, Kojima M, Watanbe R, Tsuboi M, Goto K, Ishii G. Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma. Cancer Immunol Immunother. 2023;72:2205\u201315. https:\/\/doi.org\/10.1007\/s00262-023-03393-8.","journal-title":"Cancer Immunol Immunother"},{"issue":"1090\u20131103","key":"2467_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2023.04.007","volume":"30","author":"JM Hendricks","year":"2023","unstructured":"Hendricks JM, Doubravsky CE, Wehri E, Li Z, Roberts MA, Deol KK, Lange M, Lasheras-Otero I, Momper JD, Dixon SJ, Bersuker K, Schaletzky J, Olzmann JA. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Cell Chem Biol. 2023;30(1090\u20131103): e1097. https:\/\/doi.org\/10.1016\/j.chembiol.2023.04.007.","journal-title":"Cell Chem Biol"},{"key":"2467_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115783","volume":"158","author":"C Ryan","year":"2022","unstructured":"Ryan C, Stoltzfus KC, Horn S, Chen H, Louie AV, Lehrer EJ, Trifiletti DM, Fox EJ, Abraham JA, Zaorsky NG. Epidemiology of bone metastases. Bone. 2022;158: 115783. https:\/\/doi.org\/10.1016\/j.bone.2020.115783.","journal-title":"Bone"},{"issue":"696\u2013710","key":"2467_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.12.009","volume":"111","author":"Z Shi","year":"2023","unstructured":"Shi Z, Yu P, Lin WJ, Chen S, Hu X, Chen S, Cheng J, Liu Q, Yang Y, Li S, Zhang Z, Xie J, Jiang J, He B, Li Y, Li H, Xu Y, Zeng J, Huang J, Mei J, Cai J, Chen J, Wu LJ, Ko H, Tang Y. Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8(+) T lymphocytes. Neuron. 2023;111(696\u2013710): e699. https:\/\/doi.org\/10.1016\/j.neuron.2022.12.009.","journal-title":"Neuron"},{"key":"2467_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fonc.2019.00421","volume":"9","author":"H Cheng","year":"2019","unstructured":"Cheng H, Wang Z, Fu L, Xu T. Macrophage polarization in the development and progression of ovarian cancers: an overview. Front Oncol. 2019;9:421. https:\/\/doi.org\/10.3389\/fonc.2019.00421.","journal-title":"Front Oncol"},{"key":"2467_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4196\/kjpp.2023.27.3.241","volume":"27","author":"W An","year":"2023","unstructured":"An W, Kang JS, Oh S, Tu A. MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors. Korean J Physiol Pharmacol. 2023;27:241\u201356. https:\/\/doi.org\/10.4196\/kjpp.2023.27.3.241.","journal-title":"Korean J Physiol Pharmacol"},{"key":"2467_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078128","volume":"8","author":"J Cosin-Roger","year":"2013","unstructured":"Cosin-Roger J, Ortiz-Masia D, Calatayud S, Hernandez C, Alvarez A, Hinojosa J, Esplugues JV, Barrachina MD. M2 macrophages activate WNT signaling pathway in epithelial cells: relevance in ulcerative colitis. PLoS ONE. 2013;8: e78128. https:\/\/doi.org\/10.1371\/journal.pone.0078128.","journal-title":"PLoS ONE"},{"key":"2467_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22136995.","journal-title":"Int J Mol Sci"},{"key":"2467_CR11","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA. The complex role of tumor-infiltrating macrophages. Nat Immunol. 2022;23:1148\u201356. https:\/\/doi.org\/10.1038\/s41590-022-01267-2.","journal-title":"Nat Immunol"},{"key":"2467_CR12","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1158\/1078-0432.CCR-16-3122","volume":"23","author":"JM Brown","year":"2017","unstructured":"Brown JM, Recht L, Strober S. The promise of targeting macrophages in cancer therapy. Clin Cancer Res. 2017;23:3241\u201350. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3122.","journal-title":"Clin Cancer Res"},{"key":"2467_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla K, Singh PK. Metabolic regulation of macrophage polarization in cancer. Trends Cancer. 2019;5:822\u201334. https:\/\/doi.org\/10.1016\/j.trecan.2019.10.007.","journal-title":"Trends Cancer"},{"key":"2467_CR14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.7150\/jca.81623","volume":"14","author":"X Ding","year":"2023","unstructured":"Ding X, Zhang Y, Liang J, Li Q, Hu H, Zhou Y, Zhang B. Dihydroartemisinin potentiates VEGFR-TKIs antitumorigenic effect on osteosarcoma by regulating Loxl2\/VEGFA expression and lipid metabolism pathway. J Cancer. 2023;14:809\u201320. https:\/\/doi.org\/10.7150\/jca.81623.","journal-title":"J Cancer"},{"key":"2467_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176076","volume":"959","author":"M Mei","year":"2023","unstructured":"Mei M, Tang L, Zhou H, Xue N, Li M. Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages. Eur J Pharmacol. 2023;959: 176076. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176076.","journal-title":"Eur J Pharmacol"},{"key":"2467_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.31557\/APJCP.2024.25.1.325","volume":"25","author":"R Nazmabadi","year":"2024","unstructured":"Nazmabadi R, Pooladi M, Amri J, Abbasi Y, Karami H, Darvish M. Dihydroartemisinin enhances the therapeutic efficacy of BH3 mimetic inhibitor in acute lymphoblastic leukemia cells via inhibition of Mcl-1. Asian Pac J Cancer Prev. 2024;25:325\u201332. https:\/\/doi.org\/10.31557\/APJCP.2024.25.1.325.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2467_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3892\/ol.2024.14470","volume":"28","author":"N Tang","year":"2024","unstructured":"Tang N, Liu X, Liu Y, Wang H, Zhao Y, Wang H, Hu Z. Dihydroartemisinin induces ferroptosis in T cell acute lymphoblastic leukemia cells by downregulating SLC7A11 and activating the ATF4-CHOP signaling pathway. Oncol Lett. 2024;28:337. https:\/\/doi.org\/10.3892\/ol.2024.14470.","journal-title":"Oncol Lett"},{"key":"2467_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202201257","volume":"20","author":"Z Xu","year":"2023","unstructured":"Xu Z, Zhang X, Liu J, Zhao S, Liu J, Zhou W. Design, synthesis, and biological evaluation of novel amyl ester tethered dihydroartemisinin-isatin hybrids as potent anti-breast cancer agents. Chem Biodivers. 2023;20: e202201257. https:\/\/doi.org\/10.1002\/cbdv.202201257.","journal-title":"Chem Biodivers"},{"key":"2467_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13041-022-00921-y","volume":"15","author":"Q Xiong","year":"2022","unstructured":"Xiong Q, Li X, Xia L, Yao Z, Shi X, Dong Z. Dihydroartemisinin attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting oxidative stress. Mol Brain. 2022;15:36. https:\/\/doi.org\/10.1186\/s13041-022-00921-y.","journal-title":"Mol Brain"},{"key":"2467_CR20","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.3390\/cimb44120418","volume":"44","author":"CY Wu","year":"2022","unstructured":"Wu CY, Shu LH, Liu HT, Cheng YC, Wu YH, Wu YH. The role of MRE11 in the IL-6\/STAT3 pathway of lung cancer cells. Curr Issues Mol Biol. 2022;44:6132\u201344. https:\/\/doi.org\/10.3390\/cimb44120418.","journal-title":"Curr Issues Mol Biol"},{"key":"2467_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081946","author":"E Cendrowicz","year":"2021","unstructured":"Cendrowicz E, Sas Z, Bremer E, Rygiel TP. The role of macrophages in cancer development and therapy. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13081946.","journal-title":"Cancers (Basel)"},{"key":"2467_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41467-017-02481-5","volume":"9","author":"N Linde","year":"2018","unstructured":"Linde N, Casanova-Acebes M, Sosa MS, Mortha A, Rahman A, Farias E, Harper K, Tardio E, Reyes Torres I, Jones J, Condeelis J, Merad M, Aguirre-Ghiso JA. Macrophages orchestrate breast cancer early dissemination and metastasis. Nat Commun. 2018;9:21. https:\/\/doi.org\/10.1038\/s41467-017-02481-5.","journal-title":"Nat Commun"},{"key":"2467_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","volume":"16","author":"M Li","year":"2023","unstructured":"Li M, Yang Y, Xiong L, Jiang P, Wang J, Li C. Metabolism, metabolites, and macrophages in cancer. J Hematol Oncol. 2023;16:80. https:\/\/doi.org\/10.1186\/s13045-023-01478-6.","journal-title":"J Hematol Oncol"},{"key":"2467_CR24","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2024106","author":"Y Diao","year":"2024","unstructured":"Diao Y, Huang S, Liu F, Liao S, Guan C, Xiong X, Zhang P, Li J, Zhang W, Ying Y. CCL2 promotes EGFR-TKIs resistance in non-small cell lung cancer via the AKT-EMT pathway. Acta Biochim Biophys Sin (Shanghai). 2024. https:\/\/doi.org\/10.3724\/abbs.2024106.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2467_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13560","volume":"57","author":"H Xu","year":"2024","unstructured":"Xu H, Wang J, Al-Nusaif M, Ma H, Le W. CCL2 promotes metastasis and epithelial-mesenchymal transition of non-small cell lung cancer via PI3K\/Akt\/mTOR and autophagy pathways. Cell Prolif. 2024;57: e13560. https:\/\/doi.org\/10.1111\/cpr.13560.","journal-title":"Cell Prolif"},{"key":"2467_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/2326-6066.CIR-21-0407","volume":"10","author":"T Miyamoto","year":"2022","unstructured":"Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, Takamatsu S, Mise Y, Ukita M, Taki M, Yamanoi K, Horikawa N, Abiko K, Yamaguchi K, Baba T, Matsumura N, Mandai M. B7\u2013H3 suppresses antitumor immunity via the CCL2-CCR2-M2 macrophage axis and contributes to ovarian cancer progression. Cancer Immunol Res. 2022;10:56\u201369. https:\/\/doi.org\/10.1158\/2326-6066.CIR-21-0407.","journal-title":"Cancer Immunol Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02467-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:39:43Z","timestamp":1743863983000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02467-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2467"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02467-w","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Animal Care and Use Committee of Nanjing Medical University approved all animal experiments (Permit number: IACUC-2105056).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}